Butchko Julia G.

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$381,700.00
Insider Sells Quantity
22
Insider Sells Sum
$2.72M

Insider Activity of Butchko Julia G.

According to the SEC Form 4 filings, Butchko Julia G., being in a position of

  1. Chief Development Officer at Immunovant, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 28544 shares for $882,099,
    over all time since 2020-09-11, has bought 10000 shares for $381,700, and sold 171294 shares for $2.72M.

The largest purchase of all time was on 2020-09-11 and amounted to 10000 shares of Immunovant, Inc. for $381,700.

The largest sale of all time was on 2023-01-11 and amounted to 60490 shares of Immunovant, Inc. for $1.02M.

Biography of Butchko Julia G.

No biography is available at this moment.

2024-08-21SaleImmunovant, Inc.
IMVT
Chief Development Officer
3,027
0.002%
$31.86$96,437-8.84%
2024-07-17SaleImmunovant, Inc.
IMVT
Chief Development Officer
2,867
0.0019%
$29.69$85,132-1.85%
2024-07-09SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,527
0.0011%
$28.06$42,8480%
2024-05-22SaleImmunovant, Inc.
IMVT
Chief Development Officer
3,247
0.0022%
$29.65$96,274-1.32%
2024-04-17SaleImmunovant, Inc.
IMVT
Chief Development Officer
10,115
0.0071%
$29.06$293,923+2.67%
2024-04-09SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,053
0.0007%
$31.18$32,833-6.18%
2024-02-22SaleImmunovant, Inc.
IMVT
Chief Development Officer
2,146
0.0015%
$36.15$77,578-17.78%
2024-01-05SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,297
0.0008%
$38.59$50,051-29.29%
2023-11-22SaleImmunovant, Inc.
IMVT
Chief Development Officer
3,265
0.0023%
$32.78$107,024-5.54%
2023-10-05SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,735
0.0014%
$36.24$62,885-12.62%
2023-08-24SaleImmunovant, Inc.
IMVT
Chief Development Officer
12,333
0.0095%
$20.30$250,360+62.02%
2023-07-12SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,470
0.0012%
$19.73$29,003+62.05%
2023-04-18SaleImmunovant, Inc.
IMVT
Chief Development Officer
1,544
0.0012%
$15.27$23,577+97.85%
2023-01-11SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
60,490
0.0448%
$16.79$1.02M+19.3%
2022-10-13SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
928
0.0007%
$9.18$8,519+96.15%
2022-08-30SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
548
0.0005%
$5.83$3,195+232.14%
2022-07-27SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
510
0.0004%
$4.27$2,178+272.05%
2022-06-29SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
460
0.0004%
$4.02$1,849+274.88%
2022-05-24SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
492
0.0004%
$3.79$1,865+240.21%
2022-04-27SaleImmunovant, Inc.
IMVT
Chief Dev. & Tech. Officer
541
0.0005%
$4.72$2,554+125.81%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.